Approximately 100 mg of whole-brain tissue was collected from 14.5 dpc embryos and homogenized with ceramic beads (Sapphire Bioscience) using TRIzol reagent (Life Technologies) in tissue homogenizer (Bertin Technologies). Total RNA and tRNA isolation, tRNA hydrolysis, and tRNA modification analysis via high-performance liquid chromatography coupled to mass spectrometry was performed as previously described26 (link). Mass spectrometer parameters were optimized for targeted ribonucleosides using multiple injections of 0.1–1 ng of commercially obtained m7G (MetaGene) and purified ncm5U, mcm5U, and mcm5s2U nucleosides (a generous gift from Sebastian Leidel, University of Bern, Switzerland). The obtained retention times were superimposed with the previously published results94 (link). An analytical method was developed for the simultaneous analysis of modified ribonucleosides of which six compounds of interest were targeted for quantification (ncm5U, mcm5U, mcm5s2U, Ψ, m1A, m7G, and t6A). Pseudouridine (Ψ) served as an internal normalization standard. MultiQuant v2.1.1 (AB Sciex) software was used for peak assignment, quantification, and normalization.
Free full text: Click here